Annovis Bio, Inc. DEF 14A filed 2026-09-11

Annovis Bio, Inc., listed on the NYSE under the ticker ANVS, filed a DEF 14A on 2026-09-11. This is a definitive proxy statement calling a Special Meeting of Stockholders on Wednesday, October 14, 2026, at 10:00 a.m. Eastern Time. The meeting will be held telephonically rather than in person. Only stockholders of record as of September 4, 2026 may vote, and the filing states there were 42,679,059 shares of common stock outstanding as of that Record Date. The main item is Proposal 1, an amendment to the Amended and Restated Certificate of Incorporation. It would increase authorized Common Stock from 70,000,000 to 140,000,000 shares and authorized Preferred Stock from 2,000,000 to 10,000,000 shares. For an analyst or journalist, the point of interest is the gap between the 42,679,059 shares outstanding and the proposed authorized totals, since authorized shares set the ceiling on what the company can issue without returning to stockholders. The excerpt does not state a reason for the increase or any planned use of the new shares; that is not in the filing excerpt. Proposal 2 asks stockholders to ratify an amendment to the company's Option Plan, which the table of contents identifies as the 2019 Equity Incentive Plan, to increase the shares authorized under it. The filing says this amendment was previously presented at the company's 2026 Annual Meeting, but the excerpt does not say what happened to it there or how many shares the increase covers. Proposal 3 would allow the meeting to be adjourned to solicit more proxies. The Board unanimously recommends a vote "FOR" each proposal. The filing also warns that shares held through brokers will not be voted on Proposals 1 and 2 without instructions from the holder. The notice is signed by Maria Maccecchini, President and Chief Executive Officer. The company is a Delaware corporation classified under Pharmaceutical Preparations and files as a non-accelerated filer and smaller reporting company. Vote thresholds, current beneficial ownership figures and the text of the amendments in the annexes are not in the excerpt.